Morphine COnsumption in Joint Replacement Patients, With and Without GaBapentin Treatment, a RandomIzed ControlLEd Study (MOBILE)
Multiple Doses of Gabapentin and Postoperative Morphine Consumption in Primary Hip Arthroplasty
Sponsor: Hamilton Health Sciences Corporation
Listed as NCT00889148, this NA trial focuses on Postoperative Pain and Total Hip Replacement and remains completed. Sponsored by Hamilton Health Sciences Corporation, it has been updated 5 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Oct 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hamilton Health Sciences Corporation
For direct contact, visit the study record on ClinicalTrials.gov .